HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research Feb 24, 2022
COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business highlights Feb 24, 2022
Adastra Holdings Expands Co-Manufacturing Portfolio and Provides Facility Expansion Update Feb 23, 2022
World’s First clinical trial for DMT-assisted therapy in Major Depressive Disorder Shows Consistent Quality of… Feb 22, 2022
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules Feb 17, 2022
